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Chemotherapy-induced alopecia is thought to result from
cytotoxic and apoptosis-related damage to the hair
follicle. This study was designed to confirm whether
keratinocyte apoptosis is indeed induced in growing
(J anagen) hair follicles of C57 BL/6 mice after the
injection of cyclophosphamide, using improved methods
for histologic detection of apoptotic cells in murine skin.
More importantly, we asked whether topical calcitriol-
analogs are able to modulate cyclophosphamide-induced
apoptosis in vivo, because there are conflicting reports on
the effects of calcitriols on apoptosis in vitro. Anagen was
induced in telogen mice on day 0 by depilation. Starting
on day 5 post-depilation, the back skin of mice was
topically treated with either 0.2 mg 1,25-dihydroxyvitamin
D3, 2.0 mg calcipotriol, 0.02 mg KH 1060, or vehicle
(ethanol) only. On the last day of treatment (i.e., day 9
post-depilation), all mice received 150 mg cyclophos-
phamide i.p. per kg as a single dose to induce alopecia,
Alopecia is one of the most distressing side-effects of manychemotherapeutic agents. In addition to the traumatizingstigma of hair loss there often is also a rather defectivere-growth of abnormally structured and/or discoloredhair. Although several animal studies have reported
various drugs to be effective in preventing chemotherapy-induced
alopecia (CIA; e.g., Jimenez and Yunis, 1992) or in promoting the
re-growth of normal hair shafts (Paus et al, 1994, 1996), up to now
there has been no effective and safe treatment available for this severe,
psychologically devastating hair growth disorder in oncologic patients.
One prerequisite for therapeutic progress in this rather poorly studied
field is a more detailed characterization of the pathomechanisms by
which chemotherapeutic agents damage the hair follicle, using carefully
chosen animal models (Paus et al, 1994, 1996). Although the morpho-
logic changes that occur in the hair follicle during chemotherapy were
initially described decades ago (Braun-Falco, 1961; Kostanecki and
Kwiatowska, 1966), little progress has been made in the basic under-
standing of the pathomechanisms that underlie these morphologic
changes.
It is now known that chemotherapeutic agents are potent inducers
Manuscript received October 17, 1997; revised June 8, 1998; accepted for
publication June 10, 1998.
Reprint requests to: Dr. Andreas Menrad, Experimental Oncology, Research
Laboratories, Schering AG, D-13342, Berlin, Germany.
Abbreviations: CIA, chemotherapy-induced alopecia; CYP, cyclophospham-
ide; p.d., post-depilation; TUNEL, terminal UTP nucleotide end labeling.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
598
or vehicle (aqua dist.). Analysis of the treated skin by
in situ-end labeling (using a modified terminal UTP
nucleotide end labeling technique suitable for murine
skin), by Hoechst 33342 stain, and by DNA electro-
phoresis on days 10 and 14, revealed the induction of
massive apoptosis in cyclophosphamide-treated anagen
hair bulbs, which was most prominent on day 10, whereas
controls showed no follicular apoptosis. The calcitriol-
pretreated groups demonstrated a significant reduction
of apoptosis, with a maximal inhibition seen on day 14.
This confirms that cyclophosphamide indeed induces
massive keratinocyte apoptosis in anagen hair follicles,
and provides evidence that topical calcitriol-analogs can
suppress epithelial cell apoptosis in vivo. The mouse model
employed here offers an excellent tool for dissecting
the as yet poorly understood controls of keratinocyte
apoptosis in situ and its pharmacologic manipulation. Key
words: calcitriols/hair follicle/keratinocytes. J Invest Dermatol
111:598–604, 1998
of apoptosis (Barry et al, 1990; Hickman, 1992; Dive and Wyllie, 1993;
Fisher, 1994; McDonnell et al, 1995; Thompson, 1995; Kaufmann,
1996). Evidence from both electron microscopy and the terminal UTP
nucleotide end labeling (TUNEL) method suggests that the massive
induction of apoptosis in the hair follicle is one of the mechanisms by
which cytostatic drugs damage growing (5anagen) hair follicles
(Lindner et al, 1997; Searle et al, 1975; Goldberg et al, 1990; Cece
et al, 1996).
We have recently developed an instructive mouse model for the
study of CIA that strikingly mimics key features of human CIA and
that allows us to dissect both the response of well-defined, mature,
pigmented hair follicle populations to chemotherapy-induced damage
as well as their techniques to recover from this trauma. In addition,
this model has proven to be very useful as a screening assay for studying
candidate drugs that may be employed to manipulate CIA in vivo (Paus
et al, 1994, 1995, 1996; Slominski et al, 1996). Using this mouse
model, our objective in this study was to confirm whether the
chemotherapeutic agent cyclophosphamide (CYP) induces apoptosis
in anagen hair follicles in vivo. More importantly, we wished to explore
whether topically applied calcitriol-analogs, which do not prevent CIA
but promote re-growth of normally pigmented hair in mice (Paus et al,
1995, 1996), modulate CIA-related apoptosis in the hair follicle.
Previous reports had suggested that calcitriols may either induce
(Simboli-Campbell and Welsh, 1995) or inhibit apoptosis (Xu et al,
1993) in vitro, depending on the cell type studied.
In a series of preparatory analyses of murine skin we had observed
that most of the commercially available cell death detection kits using
the TUNEL method (Gavrieli et al, 1992) seem to be customized for
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cell culture and human tissue applications, because they resulted in a
high background staining and unsatisfactory reproducibility when
murine skin was studied. Therefore, we have modified and combined
two previously described methods (Gavrieli et al, 1992; Stra¨ter et al,
1995) to improve the sensitivity, specificity, and reproducibility of
TUNEL stains in murine tissue. In addition, the usefulness of a very
simple staining method for the histologic detection of apoptotic cells
for screening purposes was explored, using the DNA-intercalating dye
Hoechst 33342.
MATERIALS AND METHODS
Chemicals 1,25-dihydroxyvitamin D3, calcipotriol, and KH 1060 (dissolved
in absolute ethanol 1 5% isopropylmyristate vol/vol) were provided by Leo
Pharmaceuticals (Ballerup, Denmark). Cyclophosphamide (Endoxan 200) was
obtained from Asta Medica (Frankfurt, Germany). Biotin-16-dUTP was
obtained from Boehringer (Mannheim, Germany); terminal deoxynucleotydil
transferase was obtained from Promega (Madison, WI); alkaline phosphatase-
conjugated streptavidin was obtained from Jackson ImmunoResearch Labora-
tories (West Grove, PA); and Hoechst 33342-dye, Fast Red Naphthol AS Mix
tablets, and BCIP/NBT tablets were obtained from Sigma (Deisenhofen,
Germany). The DNA-extraction kit was obtained from Stratagene (Heidelberg,
Germany) and the GeneScreenPlus-membrane from DuPont (Cambridge, MA).
Animals Female C57 BL/6 mice, 6–8 wk old, were purchased from Charles
River (Sulzfeld/Germany). Animals were kept on a 12 h light/dark cycle and
were fed with mousechow and water ad libitum.
Treatment of animals To induce a perfectly synchronized anagen develop-
ment over the whole back skin area, the hair shafts of the back fur coat of
mice with all follicles in telogen were depilated using a warm resin-beeswax
mixture as described before (Paus et al, 1990, 1994). On day 5 post-depilation
(p.d.), when all hair follicles were in anagen III–IV of the hair cycle (Paus et al,
1990), the back skin area was topically treated with either 0.2 µg 1,25-
dihydroxyvitamin D3, 2.0 µg calcipotriol, 0.02 µg KH 1060 (dissolved in 100 µl
ethanol), or vehicle alone. These doses had previously been established to
effectively promote hair re-growth after CIA (Paus et al, 1995, 1996). Topical
treatment was applied once daily for the next four consecutive days. On the
last day of treatment (i.e., day 9 p.d.), all test and control mice received 150 mg
CYP i.p. per kg as a single dose to induce alopecia (Paus et al, 1994). An
additional control group received only vehicle (topically and intraperitoneally).
A total of at least 15 mice per group was studied in 2–3 separate experiments.
All experiments yielded the expected macroscopic and microscopic findings
previously reported.
Preparation of skin samples Animals were sacrificed on day 10 and 14 p.d.
(10 animals per group and day). Blood and skin samples were immediately
harvested. Punch biopsies of treated skin areas were snap-frozen in liquid
nitrogen for DNA extraction. For histology, the skin was fixed in Lillie’s
formalin for 72 h, dehydrated, and then paraffin-embedded.
TUNEL of apoptotic nuclei Paraffin sections (4 µm) of the skin were
deparaffinized and rehydrated, then digested with proteinase K (20 µg per ml,
Amresco, Solon, OH) for 10 min at room temperature followed by RNAse-
digestion (2 µl per ml in Tris-buffered saline; RNAse-it from Stratagene) for
15 min at 37°C. Then the slides were incubated with UTP (40 µM stock
diluted to 2 nM; Boehringer, Mannheim, Germany) for 15 min at 37°C. After
preincubation with terminal deoxynucleotidyl transferase-buffer for 15 min at
room temperature, the sections were incubated with a mixture containing
biotin-conjugated dUTP (biotin-16-dUTP, 1.7 µl per 100 µl) and terminal
deoxynucleotidyl transferase (10 U per 100 µl) for 2 h at 37°C. The reaction
was terminated by rinsing the slides in TB-buffer (300 mM NaCl, 30 mM
sodium citrate) for 15 min at room temperature. After washing in Tris-buffered
saline the sections were incubated with alkaline-phosphatase streptavidin 1:200
in Tris-buffered saline for 30 min at 37°C. Labeled nuclei were visualized by
Fast Red dye. Sections were evaluated anonymously (i.e., in ignorance of their
group assignment) and in randomized sequence by light microscopy. The
combined treatment of the sections with RNAse, excess-UTP, and TB-Buffer
constituted significant changes in this TUNEL protocol substantially improved
the staining results on murine skin, compared with the original TUNEL method
(Gavrieli et al, 1992) and a microwave-based method (Stra¨ter et al, 1995). This
modified TUNEL protocol provides a sensitive, specific, and well reproducible
light microscopic alternative for the histologic detection of apoptotic cells to
available fluorescent detection techniques with their more limited visualization
of tissue architecture (Lindner et al, 1997).
Hoechst 33342 staining of apoptotic bodies This method was adapted
for histology from previously reported fluorescence-activated cell sorter methods
(Chrest et al, 1993). Paraffin sections (4 µm) of the skin were deparaffinized in
xylene and ethanol. After rehydration in phosphate-buffered saline, the tissue
sections were incubated with a 10 µg per ml solution of the fluorescent Hoechst
33342 dye in phosphate-buffered saline for 1 h at room temperature in the
dark. After washing in tap water, the slides were mounted and evaluated by
fluorescence microscopy at 510 nm. Due to the simplicity and cost efficiency
of this technique, we wished to explore whether it can serve as a fast method
for high-throughput screening of tissue sections for differences in apoptotic
cells between test and control groups.
Statistical evaluation and analysis For the morphometric analysis of the
skin sections, defined, standardized back skin areas of test and control mice
were examined and compared with each other. From each animal, at least 20
follicles were evaluated by light- and fluorescence microscopy at 4003
magnification using a Zeiss microscope.
For the TUNEL analysis only small, condensed, and thus intensively red
stained nuclei were considered to represent apoptotic nuclei. This rigid cut-off
criterion was selected in order to minimize the risk of false positive counts
(e.g., due to necrosis or background staining). Because the Hoechst 33342 dye
nonspecifically intercalates with the DNA and thus marks all DNA-containing
cells, likewise in the TUNEL analysis, only small and intensively labeled nuclei
and apoptotic bodies (in comparison with surrounding cells) were counted as
reliable indicators for apoptosis.
Statistical evaluation was performed on at least 20 follicles per animal, and
the mean for this animal was calculated. Subsequently, the mean (6SEM) of
all animals from one group and day was calculated; p values were calculated by
using the Mann–Whitney U Wilcoxon test.
Gel electrophoresis/blotting of fragmented DNA Total DNA was isol-
ated from snap-frozen skin punches (8 mm) of histology-corresponding back
skin areas, using a commercially available DNA-extraction kit. DNA fragments
were separated by agarose gel electrophoresis (2% agarose) and visualized by
staining with ethidium bromide (Cotter and Martin, 1996). Due to the
relatively small number of apoptotic nuclei compared with the vast majority of
nonapoptotic cells in full-thickness mouse skin, as demonstrated by histology
(i.e., TUNEL and Hoechst stain), there was no distinct fragmentation (i.e.,
laddering) detectable on the gel, following this routine protocol.
To enhance the detection of fragmented DNA, we therefore combined and
modified two highly sensitive, but radioactive methods (Huang and Plunkett,
1992; Tilly and Hsueh, 1993) to generate a nonradioactive method, based on
39-end-labeling. Like in the TUNEL stain, the isolated DNA was incubated
with biotin-16-dUTP and terminal deoxynucleotidyl transferase for 2 h at
37°C. The reaction was terminated by heating to 70°C for 10 min. DNA was
precipitated by ethanol overnight at –20°C and a gel electrophoresis was
performed as described above. The DNA was then blotted by vacuum
(25 mmHg, 2 h) on a GeneScreenPlus membrane and air-dried overnight.
After blocking for 1 h in phosphate-buffered saline with 0.5% Tween 20 and
2% bovine serum albumin, the membrane was incubated for 1 h with alkaline-
phosphatase streptavidin 1:2000 in phosphate-buffered saline with 0.05% Tween
20 and 2% bovine serum albumin. After a washing step, the labeled DNA was
visualized using BCIP/NBT as substrate. Densitometry was performed on the
negative film of the photographed membrane using the Personal Densitometer
SE and ImageQuaNT software (both from Molecular Dynamics, Sunny
Vale, CA).
Serum-calcium The serum calcium level for each individual animal was
obtained by flame-photometry (Keller, 1986), and was found to remain unaltered
by the application of calcitriols throughout the course of the experiments
(not shown).
RESULTS
Cyclophosphamide induces apoptosis in murine anagen VI hair
follicles To confirm that CYP induces apoptosis in murine anagen
hair follicles, skin sections of CYP-treated mice were stained by using
a modification of the biochemical in situ end labeling technique
(TUNEL), specifically developed for light-microscopic evaluation of
apoptosis in murine skin sections (see Materials and Methods). Compared
with routine TUNEL techniques (Gavrieli et al, 1992; Stra¨ter et al,
1995), the sections were digested with RNAse to reduce background
staining. Another step to quench background staining was to saturate
unspecific UTP-binding sites in murine skin by providing excess UTP
to the sections prior to applying the actual terminal deoxynucleotidyl
transferase/biotin-16-dUTP mixture. The TB-buffer was applied to
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Figure 1. C57 BL/6 mouse skin sections
stained by TUNEL. Apoptotic nuclei in the
bulb region after different in vivo treatments.
(A) Positive staining control, i.e., untreated
murine skin treated with DNAse prior to
TUNEL, thus all DNA is fragmented and all
nuclei positively stained. Note the size and the
dispersed chromatin of these nuclei of normal,
nonapoptotic follicle cells compared with the
marked small apoptotic nuclei in (C), (D), (F),
and (G). For day 10: (B) control (without
CYP), (C) CYP-treated, and (D) CYP 1
calcitriol treated animals. For day 14: (E) control
(without CYP), (F) CYP-treated, and (G)
CYP 1 calcitriol. Arrows indicate apoptotic
cells. Scale bar: 25 µm.
terminate the labeling reaction. These three steps resulted in substantially
more specific and highly reproducible staining results for apoptotic
cells in murine skin, and can serve as a convenient alternative to
fluorescent apoptosis detection techniques with their poor demarcation
of tissue architecture (Lindner et al, 1997).
This technique revealed the induction of massive keratinocyte
apoptosis by CYP in all anagen hair follicles, with most apoptotic cells
located in the hair bulb, as reflected by the amount of stained apoptotic
nuclei (Figs 1, 2). Only a few nuclei were stained in the epidermis and
interfollicular dermis of treated animals. The maximum of intrafollicular
apoptosis was seen on day 10 p.d., i.e., 24 h after CYP administration,
with hair follicles being in the anagen VI-phase of the hair cycle.
Importantly, only sections from an identical back skin region of test
and control mice were compared, and apoptosis was compared only
between hair follicles of identical hair cycle stages. Vehicle-treated
control mice revealed no TUNEL-positive nuclei in the bulb on both
investigated days.
These data were confirmed histochemically by staining of apoptotic
bodies with Hoechst 33342 dye (Figs 3, 4) as well as biochemically
by DNA-gel electrophoresis and blotting (Fig 5). A total of 20 µg
ethidium bromide-labeled DNA per lane isolated from full-thickness
back skin with its predominance of nonapoptotic cells failed to
demonstrate ‘‘laddering’’ in a regular agarose gel electrophoresis, yet
attested to the absence of loading error (not shown). Therefore, a
more sensitive detection method was applied by blotting of DNA,
which was end-labeled with biotin-16-dUTP. This clearly displayed a
distinct fragmentation of the DNA in the skin of CYP-treated mice,
which was absent in vehicle-treated control skin (Fig 5). As positive
controls, DNA from HL-60 cells was used, which had been treated
with 1 µM of camptothecin for 4 h to induce apoptosis (Li et al, 1994).
Topical pretreatment with calcitriol-analogs reduces cyclophos-
phamide-induced follicular apoptosis As reported before (Paus
et al, 1995, 1996), topical pretreatment with calcitriol, calcipotriol, or
KH 1060 failed to suppress the occurrence of CYP-induced alopecia
(macroscopically) and follicle dystrophy (microscopically). Histologic
examination of comparable back skin regions by the modified TUNEL
and Hoechst 33342 stains as reported above, revealed that apoptosis
was induced in all animals treated with CYP plus any of the three
tested calcitriols (calcitriol, calcipotriol, KH 1060). This suggests
that topical calcitriols cannot completely protect keratinocytes from
apoptosis in this model. Remarkably, there was almost no apoptosis
seen in the epidermis (not shown), dermis, and subcutis (Fig 1C, D,
F, G), in striking contrast to the bulb region of the anagen hair follicles
(Fig 1C, D, F, G). The range of labeled apoptotic cells covered all
stages of apoptosis from early changes with almost regular sized nuclei,
to condensed nuclei and finally apoptotic bodies.
In comparison with animals treated with CYP 1 topical vehicle,
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Figure 2. Statistical analysis of TUNEL morphometry. The morphometry
data (see Materials and Methods) were pooled from n 5 10 animals per group
and day, representing the amount of apoptotic nuclei per follicle as determined
by evaluating 200 follicles per group and day. (A) Day 10, (B) day 14. Means 6
SEM are given, the level of significance compared with the CYP group (only
vehicle as topical treatment) is indicated as ***p , 0.005.
however, there was a significant reduction in the number of apoptotic
nuclei (TUNEL) and apoptotic bodies (Hoechst 33342) in the CYP 1
calcitriol-treated groups on day 10 and, even more pronounced, on
day 14 (Figs 1–4). On this day, calcipotriol and KH 1060-treated
follicles showed slightly fewer apoptotic nuclei than calcitriol, although
these differences between the calcitriol analogs were not significant on
both days, when statistically compared (p values ranging from 0.03 to
0.70, with regard to a preset level of significance of p , 0.01).
Gel electrophoresis and consecutive blotting were used as additional
methods in order to qualitatively verify these quantitative histologic
data. A more intense laddering was seen in the CYP 1 vehicle-treated
group than in the CYP 1 calcitriol-treated groups (Fig 5). No
fragments could be detected in vehicle-treated controls. On day 14
p.d., a modest fragmentation was only present in the CYP group, and
the other groups showed no distinct laddering at all. Semiquantitative
analysis of the blot by densitometry showed an inhibition of DNA
laddering in the CYP 1 calcitriol group of 56% on day 10 and 61%
on day 14, respectively, compared with CYP 1 vehicle-treated
controls. Calcipotriol and KH 1060 revealed similar rates of inhibition
as calcitriol, with most dramatic effects on day 14 (Fig 6).
Irrespective of the discrete difference between the tested calcitriols
with regard to CYP-induced apoptosis in murine anagen hair follicles,
our data suggest an apoptosis-inhibitory effect of this entire group of
substances on follicular apoptosis in vivo. Because there were no
differences in serum calcium levels between calcitriol-pretreated versus
vehicle-pretreated animals (not shown), this renders it unlikely that
systemic calcium effects of the tested calcitriols might have exerted the
observed inhibition of apoptosis; however, it cannot be excluded that
local calcium-mediated effects were involved in the inhibition of
intrafollicular apoptosis by calcitriols in murine skin. The proximal
hair bulbs of vehicle-control follicles as well as those from animals
pretreated with topical calcitriol alone showed no significant apoptosis
on both examined days (not shown), supporting the hypothesis that
massive apoptosis is genuinely induced by CYP, and is inhibited by
calcitriols, but is not a major physiologic or calcitriol-induced process
during the investigated hair cycle time points (early and middle
anagen VI).
DISCUSSION
The effects of cytostatic agents on the hair follicle have been studied
for decades, and chemotherapy-induced follicle dystrophy by various
substances has been described, e.g., in human scalp skin (Braun-Falco,
1961; Kostanecki and Kwiatowska, 1966), rats (Jimenez and Yunis,
1992), and mice (Paus et al, 1994, 1995, 1996; Slominski et al, 1996);
however, the pathobiologic mechanisms that underlie chemotherapy-
induced follicle damage, which is morphologically characterized, e.g.,
by bulging of the dermal papilla, kinking and distension of the follicular
canal, and disruption of the melanogenic apparatus (Braun-Falco, 1961;
Kostanecki and Kwiatowska, 1966; Paus et al, 1994; Slominski et al,
1996), remain to be dissected in detail. Clearly, the pathomorphology
of CIA and the increasing appreciation of cytostatic drugs as potent
apoptosis-inducers (Barry et al, 1990; Hickman, 1992; Davidoff and
Mendelow, 1993; Dive and Wyllie, 1993; Fisher, 1994; Meyn et al,
1994; McDonnell et al, 1995; Thompson, 1995) suggest that keratino-
cyte apoptosis in the hair bulb of actively growing (i.e., anagen) hair
follicles plays a key role in the development of CIA (Goldberg et al,
1990; Paus, 1996; Paus et al, 1994; Cece et al, 1996).
Using three complementary, mutually confirmatory, independent
biochemical and/or morphologic techniques for the detection of
apoptosis, whose combined results renders it unlikely that necrotic
rather than apoptotic cell death was measured (Grasl-Kraupp et al,
1995), we demonstrate here that CYP does induce massive keratinocyte
apoptosis in the proximal epithelial bulbs of anagen VI pelage hair
follicles in the back skin of C57 BL/6 mice. This is in line with the
demonstration that CYP induces apoptosis in some murine tumors
(Meyn et al, 1994), as well as in human scalp hair follicles (Goldberg
et al, 1990) in vivo, and with the effects of doxorubicin in hair follicles
of newborn rats (Cece et al, 1996).
Taken together, these findings further support the concept that the
induction of apoptosis is a standard response of the hair follicle to
damage (Paus et al, 1993; Paus and Czarnetzki, 1994), and confirms
our previous detection of murine, CYP-induced follicular apoptosis,
using a fluorescent TUNEL technique (Lindner et al, 1997). We
demonstrate that the bulb region of the follicle with its rapidly
proliferating epithelial cell populations is the major target of CYP-
induced damage in murine skin under assay conditions. Moreover, we
document that topically administered calcitriols significantly reduce the
degree of intrafollicular apoptosis induced by CYP, even though they
do not completely suppress apoptosis. These findings are important in
several aspects.
First, they underscore the significance of keratinocyte apoptosis in
the pathogenesis of CIA and lend further credence to the concept that,
in addition to their cytotoxic effects, the induction of apoptosis
represents a common mode of action of many chemotherapeutic agents
(Marks and Fox, 1991; Fisher, 1994; McDonnell et al, 1995), even
though this does not explain yet how these compounds induce the
loss of hair shafts. The discrete and nonsignificant differences observed
between calcitriol, calcipotriol, and KH 1060 in the reduction of CYP-
induced apoptosis are most likely drug related. Contrary to a more
optimistic report from a neonatal rat model of CIA (Jimenez and
Yunis, 1992), topical calcitriols failed to suppress the occurrence of
visible alopecia and follicle dystrophy after CYP treatment of mature,
pigmented anagen VI follicles (i.e., of those follicles that are the real
target for human CIA; Paus et al, 1996) in this murine model.
Second, the inhibitory properties of topical calcitriols on follicle
keratinocyte apoptosis documented here provide the first evidence that
vitamin D3 analogs – directly or indirectly – inhibit rather than
induce the apoptosis of normal epithelial cells in vivo. The observed
downregulation of apoptosis in CYP-treated hair follicles by topical
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Figure 3. Histologic sections stained by
Hoechst 33342 dye. Comparison of the
amount of apoptotic bodies in the bulb region.
For day 10: (A) control (without CYP), (B)
CYP-treated, and (C) CYP 1 calcitriol treated
animals. For day 14: (D) control (without CYP),
(E) CYP-treated, and (F) CYP 1 calcitriol.
Note that lumps of small stained apoptotic
bodies lying very closely were counted as one
unit, i.e., one apoptotic nucleus. Arrows indicate
apoptotic cells. Scale bar: 25 µm.
calcitriols is in line with the report that calcitriol can protect HL-60
cells from apoptosis in vitro (Xu et al, 1993). The effects reported here
likely result from genomic interactions of the ligand-vitamin D3
receptor-complex with apoptosis-control genes like members of the
Bcl-family (Xu et al, 1993), which seem to be involved in regulating
keratinocyte apoptosis during spontaneous hair follicle regression (Paus
et al, 1993; Polakowska et al, 1994; Stenn et al, 1994; Lindner et al,
1997) and which may control chemotherapy-induced apoptosis (Fisher,
1994; Dole et al, 1995; McDonnell et al, 1995; Thompson, 1995).
Interestingly, we have recently demonstrated that CYP treatment
potently upregulates the expression of pro-apoptotic elements (Fas/
Apo-1, ICE, p55TNFR, Bax) in the anagen hair bulb, whereas follicular
Bcl-2 immunoreactivity becomes almost undetectable (Lindner et al,
1997). Therefore, we are currently testing how calcitriols effect follicular
expression of these parameters of the apoptosis control machinery in
CYP-damaged hair follicles. Calcitriol treatment may also induce a
change in hair matrix keratinocyte proliferation and/or terminal
differentiation (Reichrath et al, 1994). This might render follicle
keratinocytes less susceptible to the cytotoxic and/or pro-apoptotic
effects of CYP. Because the cell cycle and differentiation state of
keratinocytes may well affect their propensity to undergo apoptosis
(Fisher, 1994; Thompson, 1995; White, 1996; Mitra et al, 1997), we
are currently also studying how calcitriols alter epithelial proliferation
and differentiation parameters in the murine hair follicle.
Third, the apoptosis of normal keratinocytes in situ is probably
dependent on ‘‘social controls of cell survival and death’’ (Raff et al,
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Figure 4. Statistical analysis of Hoechst 33342 morphometry. The
morphometry data were pooled from n 5 10 animals per group and day
representing the amount of apoptotic nuclei in 200 follicles per group and day.
(A) Day 10, (B) day 14. Means 6 SEM are given, the level of significance
compared with the vehicle group is indicated as ***p , 0.005.
1993), which are exerted by the intraepithelial signaling milieu installed
in loco, and by the characteristics of the cell cycle machine of CYP-
damaged cells at the time of cytostatic drug exposure (Paus et al, 1993;
Polakowska and Haake, 1994; Polakowska et al, 1994; White, 1996;
Lindner et al, 1997). Therefore, it is critically important to study the
control of keratinocyte apoptosis in vivo rather than in vitro, and to
study this as much as possible in the context of pro- and anti-apoptotic
extra- and intracellular signals, received by a given keratinocyte
population at the time of drug-induced cell damage.
Fourth, our study demonstrates that cytostatic agents like CYP can
greatly exaggerate the naturally occurring rate of intrafollicular epithelial
cell-apoptosis that is employed during hair follicle development and
during the spontaneous, cyclic regression of the hair bulb (5catagen)
for modeling follicle morphogenesis, for maintaining epithelial tissue
homeostasis, and for remodeling the cycling proximal portion of the
hair follicle (Wheedon and Strutton, 1981; Lindner et al, 1997). With
a fluorescent TUNEL method it was demonstrated that murine hair
follicles in late anagen VI have TUNEL-positive cells in the central
and distal inner root sheath and in the isthmus/bulge region of the
distal outer root sheath (Lindner et al, 1997); however, an extended
analysis of follicular apoptosis during all stages of normal murine hair
follicle morphogenesis and cycling has recently revealed that the murine
proximal hair bulb is not TUNEL positive until catagen is initiated.1
1Magerl M, Lindner G, Botchkareva N, Paus R: Patterns of proliferation
and apoptosis during murine hair follicle morphogenesis and cycling. J Invest
Dermatol 110:532a, 1998 (abstr.)
Figure 5. Blot of isolated DNA from the back skin. On day 10 p.d., all
CYP-treated groups display a visible laddering, whereas on day 14 p.d. there
is only a distinct fragmentation in the CYP group. The lane with the extensive
laddering is DNA from camptothecin-pretreated, apoptotic HL-60 cells as
positive fragmentation control.
Figure 6. Semiquantitative densitometry. Densitometry was performed on
the blot shown in Fig 5, and the relative grade of inhibition of fragmentation
in the CYP 1 calcitriol groups compared with CYP 1 vehicle was calculated
by setting the CYP values as 100% fragmentation. These data revealed an
inhibitory effect in the CYP 1 calcitriol groups on day 10 and day 14 p.d.
Figures 1 and 3 display this proximal area of murine hair follicles in
anagen VI with apoptotic changes due to CYP treatment.
It remains to be defined whether the downregulation of CYP-
induced apoptosis parameters by topical calcitriols reflects direct inter-
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actions of the selected vitamin D analogs with the vitamin D receptors
of follicular keratinocytes, or with those of other resident cell popula-
tions [e.g., dermal papilla fibroblasts (Reichrath et al, 1994), perifollicular
macrophages, and mast cells], which subsequently modulate follicular
keratinocyte apoptosis. Also, in order to explain differences in the pro-
and anti-apoptotic properties of various vitamin D analogs, it needs to
be better characterized which apoptosis control-genes relevant to
keratinocyte apoptosis display vitamin D response elements, how
various vitamin D ligand-receptor complexes differ in their affinity to
these response elements, and which interactions between calcitriol
receptors and other ligand-nuclear hormone-receptor complexes occur
in a given cell type in situ (Braun et al, 1995; Leblanc and Stunnenberg,
1995; Mangelsdorf et al, 1995). Also, one would like to know to what
extent the hair follicle, which exhibits abundant vitamin D-receptors
and expresses them in a hair cycle-dependent fashion (Reichrath et al,
1994), employs locally synthesized calcitriols to control its rate of
keratinocyte apoptosis during physiologic hair follicle regression.
Finally, it deserves further systematic exploration whether the select-
ive suppression of intrafollicular apoptosis, e.g., by topical calcitriols
administered in hair follicle-targeting liposome preparations (Li et al,
1992; Li and Hoffman, 1995), may be used therapeutically to protect
growing hair follicles from chemotherapy-induced hair loss without
endangering the efficacy of cytostatic drugs in the elimination of
malignant cells, particularly of extrafollicular scalp skin metastases.
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